China Tian Yuan Healthcare Group Limited (0557:HK) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the China Tian Yuan Healthcare Group Limited stock forecast from 0 analysts, the average analyst target price for China Tian Yuan Healthcare Group Limited is not available over the next 12 months. China Tian Yuan Healthcare Group Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of China Tian Yuan Healthcare Group Limited is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, China Tian Yuan Healthcare Group Limited’s stock price was HKD 0.87. China Tian Yuan Healthcare Group Limited’s stock price has changed by +0.00% over the past week, +17.57% over the past month and -45.96% over the last year.
No recent analyst target price found for China Tian Yuan Healthcare Group Limited
No recent average analyst rating found for China Tian Yuan Healthcare Group Limited
Company Overview China Tian Yuan Healthcare Group Limited
China Tian Yuan Healthcare Group Limited, an investment holding company, provides healthcare related services in Hong Kong, Korea, and the People's Republic of China. It operates through Investment Holding, Healthcare, Money Lending and Related Business, and Hospitality segments. The company offers procurement, marketing, and management services to the medical industry; and plastic surgery and medical beauty services, as well as licenses trademarks. It also invests in equity investments and marketable equitable equity mutual funds; offers loans and related services; refers and introduces lenders and borrowers; and provides procurement services to hospitality industry. The company was formerly known as City e-Solutions Limited and changed its name to China Tian Yuan Healthcare Group Limited in November 2017. The company was incorporated in 1990 and is based in Wan Chai, Hong Kong. China Tian Yuan Healthcare Group Limited is a subsidiary of Tian Yuan Manganese Limited. Address: Sun Hung Kai Centre, Wan Chai, Hong Kong Read Less
China Tian Yuan Healthcare Group Limited, an investment holding company, provides healthcare related services in Hong Kong, Korea, and the People's Republic of China. It operates through Investment Holding, Healthcare, Money Lending and Related Business, and Hospitality segments....Read More
Frequently Asked Questions About China Tian Yuan Healthcare Group Limited (0557:HK) Stock
Stock Target Advisor's fundamental analysis for China Tian Yuan Healthcare Group Limited's stock is Bearish.
Unfortunately we do not have enough data on 0557:HK's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 0557:HK's stock to indicate what its average analyst target is.
0557:HK stock's Price/Earning ratio is 13.45.
Our analysis grades 0557:HK stock's Price / Earning ratio at D+. This means that 0557:HK stock's Price/Earning ratio is above 31.00000000000001% of the stocks in the Medical Care Facilities sector in the HK exchange.
Based on this 0557:HK may be fairly valued for its sector
The last closing price of 0557:HK's stock was HKD 0.87.
The most recent market capitalization for 0557:HK is HKD 0.35B.
Unfortunately we do not have enough analyst data on 0557:HK's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains China Tian Yuan Healthcare Group Limited's stock.
As per our most recent records China Tian Yuan Healthcare Group Limited has 0 Employees.
China Tian Yuan Healthcare Group Limited's registered address is Room Nos. 1120-1126, Wan Chai, Hong Kong.
You can get more information about it from China Tian Yuan Healthcare Group Limited's website at http://www.tianyuanhealthcare.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 0557:HK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
